The Association of OLFM4 with the Progression and Cisplatin Resistance of Head and Neck Squamous Carcinoma
Head and neck squamous cell carcinoma (HNSCC) is a highly prevalent malignant tumor globally with a poor prognosis. Despite continuous advancements in treatment modalities, the molecular mechanisms underlying its progression and chemotherapy resistance remain unclear. In previous studies, cisplatin...
Saved in:
| Main Authors: | Xinlu He, Xi Yao, Keling Pang, Xulin Chen, Zhengbo Wei, Ying Xie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Current Oncology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1718-7729/32/5/276 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of neoadjuvant chemotherapy with docetaxel and cisplatin in patients with squamous cell carcinoma of the oral cavity at high risk of progression
by: S. I. Kutukova, et al.
Published: (2025-07-01) -
Cisplatin‐coordinated copolythiophene for synergistic chemotherapy and sonodynamic therapy of tumor
by: Yuanyu Tang, et al.
Published: (2024-09-01) -
Cisplatin and the Dissolution of Electrodes in Electrochemistry Experiments
by: Ross Milton, et al.
Published: (2025-02-01) -
Cisplatin, the Timeless Molecule
by: Annaluisa Mariconda, et al.
Published: (2025-07-01) -
The Protective Effect of Resveratrol on Cisplatin Induced Damage in Rat Liver
by: Ozlem Kara, et al.
Published: (2022-09-01)